Medical Device News Magazine

NovApproach Spine Elects Sigurd H. Berven, MD, to Board

Spine Expert Supports Commercialization of New Interbody Fusion Device

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

NovApproach Spine, developer of the patented OneLIF™ interbody spinal fusion system, which supports a multitude of surgical approaches, announced today the election of orthopaedic surgeon Sigurd Berven, MD, to its board of managers. Berven is the chief of spine service and professor of orthopedic surgery at the University of California, San Francisco (UCSF). A member of NovApproach’s OneLIF design team, Berven was the first to use the implant in spine surgery.

NovApproach CEO Raymond Cloutier reports, “Dr. Berven has been a chief contributor to the OneLIF cage’s evolution. A world-renowned expert in treating spinal disorders, he brings clinical, research and academic perspectives that will strengthen our company’s ability to deliver clinically relevant solutions. It’s an honor to have his guidance during our company’s rapid growth.”

According to Berven, “It’s been truly rewarding to collaborate with the OneLIF design team. Since performing the first surgery with this versatile cage, I found its unique versatility particularly helpful for patients with both standard and challenging anatomic conditions. I’m proud to join NovApproach’s board as we expand adoption of OneLIF to benefit many surgeons and their patients.”

The OneLIF system offers surgeons a groundbreaking solution: a single cage that supports three distinct approaches to the patient’s lumbar spine: Anterior Lumbar Interbody Fusion (ALIF), the LateralATP™ Approach and the SupineATP® Approach. This enables surgeons to optimize their approach while the OneLIF cage’s six fixation screw options and two inserter positions offer unprecedented flexibility to address varying patient anatomies.

Dr. Berven’s journey is marked by academic excellence, including completing his studies at Stanford University and Oxford University, earning his medical degree from Harvard Medical School, and completing a spine surgery fellowship at UCSF. He is widely recognized for his expertise and frequently speaks at national and international conferences on advanced techniques in spinal surgery. Dr. Berven will share his experience with OneLIF during scheduled times at NovApproach’s educational exhibit #2507 at the 2023 North American Spine Society Annual Meeting, Oct. 18 – 21 in Los Angeles.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”